For many years, the role of TP53 as a tumour marker in many other tumours has been extensively studied, including in PT; however, the utility of this protein as a prognostic biomarker has remained uncertain (Niezabitowski et al., 2001; Aydoğanet al., 2016). The gene discussed is TP53; the disease is neoplasm.